Neutral
This article highlights Praxis Precision Medicines, Inc. (NASDAQ: PRAX) as one of the best biotech stocks favored by billionaire Steve Cohen's Point72...
Neutral
Praxis Precision Medicines, Inc. is holding its 2026 virtual annual meeting on June 10, 2026, where stockholders will vote on the election of three Cl...
Praxis Precision Medicines (PRAX) has achieved two significant FDA milestones: Priority Review for relutrigine in pediatric epilepsy, with a PDUFA dat...